{"id":824419,"date":"2025-03-11T13:43:07","date_gmt":"2025-03-11T17:43:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/"},"modified":"2025-03-11T13:43:07","modified_gmt":"2025-03-11T17:43:07","slug":"nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/","title":{"rendered":"NASDAQ: MRVI Lawsuit Alert: Investors with substantial losses from shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) purchased between Aug. 2024 and Feb. 2025 should contact the Shareholders Foundation"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">SAN DIEGO<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">March 11, 2025<\/span><\/span> \/PRNewswire\/ &#8212; The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI).<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1733185\/Shareholders_Foundation_Logo_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1733185\/Shareholders_Foundation_Logo_Logo.jpg\" title=\"Shareholders Foundation&#xA;mail@shareholdersfoundation.com&#xA;(8585)779-1554 (PRNewsfoto\/Shareholders Foundation, Inc.)\" alt=\"Shareholders Foundation&#xA;mail@shareholdersfoundation.com&#xA;(8585)779-1554 (PRNewsfoto\/Shareholders Foundation, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Investors who purchased a significant number of shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) between <span class=\"xn-chron\">August 7, 2024<\/span> and <span class=\"xn-chron\">February 24, 2025<\/span> have certain options and should contact the Shareholders Foundation at <a href=\"mailto:mail@shareholdersfoundation.com\" rel=\"nofollow\">mail@shareholdersfoundation.com<\/a> or call +1(858) 779 &#8211; 1554.<\/p>\n<p>On <span class=\"xn-chron\">February 24, 2025<\/span>, an investor in NASDAQ: MRVI shares filed a lawsuit against Maravai LifeSciences Holdings, Inc. over <span class=\"\" title=\"\"><span class=\"\" title=\"\">alleged<\/span><\/span> securities laws violations. The plaintiff claimed that the defendants failed to disclose to investors that Maravai LifeSciences Holdings lacked adequate internal controls over financial reporting related to revenue recognition, that as a result, the Company inaccurately recognized revenue on certain transactions during fiscal 2024, that its goodwill was overstated, and that, as a result of the foregoing, Defendants&#8217; positive statements about the Company&#8217;s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis.<\/p>\n<p>Those who purchased shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) should contact the Shareholders Foundation, Inc.<\/p>\n<p>CONTACT:<br \/>Shareholders Foundation, Inc.\u00a0<br \/>Michael Daniels\u00a0<br \/>+1 (858) 779-1554\u00a0<br \/><a href=\"mailto:mail@shareholdersfoundation.com\" target=\"_blank\" rel=\"nofollow\">mail@shareholdersfoundation.com<\/a>\u00a0<br \/>3111 Camino Del Rio North\u00a0<br \/>Suite 423\u00a0<br \/><span class=\"xn-location\">San Diego, CA<\/span> 92108<\/p>\n<p>The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock\/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and\/or settlements are not filed\/initiated\/reached and\/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC38251&amp;sd=2025-03-11\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholders-foundation-302398716.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholders-foundation-302398716.html<\/a><\/p>\n<p>SOURCE  Shareholders Foundation, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=DC38251&amp;Transmission_Id=202503111340PR_NEWS_USPR_____DC38251&amp;DateId=20250311\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire SAN DIEGO , March 11, 2025 \/PRNewswire\/ &#8212; The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Investors who purchased a significant number of shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025 have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 &#8211; 1554. On February 24, 2025, an investor in NASDAQ: MRVI shares filed a lawsuit against Maravai LifeSciences Holdings, Inc. over alleged securities laws violations. The plaintiff claimed that the defendants failed to disclose to investors that Maravai LifeSciences Holdings lacked adequate internal controls over financial reporting related to revenue &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NASDAQ: MRVI Lawsuit Alert: Investors with substantial losses from shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) purchased between Aug. 2024 and Feb. 2025 should contact the Shareholders Foundation&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-824419","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NASDAQ: MRVI Lawsuit Alert: Investors with substantial losses from shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) purchased between Aug. 2024 and Feb. 2025 should contact the Shareholders Foundation - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NASDAQ: MRVI Lawsuit Alert: Investors with substantial losses from shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) purchased between Aug. 2024 and Feb. 2025 should contact the Shareholders Foundation - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN DIEGO , March 11, 2025 \/PRNewswire\/ &#8212; The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Investors who purchased a significant number of shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025 have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 &#8211; 1554. On February 24, 2025, an investor in NASDAQ: MRVI shares filed a lawsuit against Maravai LifeSciences Holdings, Inc. over alleged securities laws violations. The plaintiff claimed that the defendants failed to disclose to investors that Maravai LifeSciences Holdings lacked adequate internal controls over financial reporting related to revenue &hellip; Continue reading &quot;NASDAQ: MRVI Lawsuit Alert: Investors with substantial losses from shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) purchased between Aug. 2024 and Feb. 2025 should contact the Shareholders Foundation&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-11T17:43:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1733185\/Shareholders_Foundation_Logo_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NASDAQ: MRVI Lawsuit Alert: Investors with substantial losses from shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) purchased between Aug. 2024 and Feb. 2025 should contact the Shareholders Foundation\",\"datePublished\":\"2025-03-11T17:43:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\\\/\"},\"wordCount\":331,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1733185\\\/Shareholders_Foundation_Logo_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\\\/\",\"name\":\"NASDAQ: MRVI Lawsuit Alert: Investors with substantial losses from shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) purchased between Aug. 2024 and Feb. 2025 should contact the Shareholders Foundation - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1733185\\\/Shareholders_Foundation_Logo_Logo.jpg\",\"datePublished\":\"2025-03-11T17:43:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1733185\\\/Shareholders_Foundation_Logo_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1733185\\\/Shareholders_Foundation_Logo_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NASDAQ: MRVI Lawsuit Alert: Investors with substantial losses from shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) purchased between Aug. 2024 and Feb. 2025 should contact the Shareholders Foundation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NASDAQ: MRVI Lawsuit Alert: Investors with substantial losses from shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) purchased between Aug. 2024 and Feb. 2025 should contact the Shareholders Foundation - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/","og_locale":"en_US","og_type":"article","og_title":"NASDAQ: MRVI Lawsuit Alert: Investors with substantial losses from shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) purchased between Aug. 2024 and Feb. 2025 should contact the Shareholders Foundation - Market Newsdesk","og_description":"PR Newswire SAN DIEGO , March 11, 2025 \/PRNewswire\/ &#8212; The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Investors who purchased a significant number of shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025 have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 &#8211; 1554. On February 24, 2025, an investor in NASDAQ: MRVI shares filed a lawsuit against Maravai LifeSciences Holdings, Inc. over alleged securities laws violations. The plaintiff claimed that the defendants failed to disclose to investors that Maravai LifeSciences Holdings lacked adequate internal controls over financial reporting related to revenue &hellip; Continue reading \"NASDAQ: MRVI Lawsuit Alert: Investors with substantial losses from shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) purchased between Aug. 2024 and Feb. 2025 should contact the Shareholders Foundation\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-11T17:43:07+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1733185\/Shareholders_Foundation_Logo_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NASDAQ: MRVI Lawsuit Alert: Investors with substantial losses from shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) purchased between Aug. 2024 and Feb. 2025 should contact the Shareholders Foundation","datePublished":"2025-03-11T17:43:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/"},"wordCount":331,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1733185\/Shareholders_Foundation_Logo_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/","name":"NASDAQ: MRVI Lawsuit Alert: Investors with substantial losses from shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) purchased between Aug. 2024 and Feb. 2025 should contact the Shareholders Foundation - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1733185\/Shareholders_Foundation_Logo_Logo.jpg","datePublished":"2025-03-11T17:43:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1733185\/Shareholders_Foundation_Logo_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1733185\/Shareholders_Foundation_Logo_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nasdaq-mrvi-lawsuit-alert-investors-with-substantial-losses-from-shares-of-maravai-lifesciences-holdings-inc-nasdaq-mrvi-purchased-between-aug-2024-and-feb-2025-should-contact-the-shareholder\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NASDAQ: MRVI Lawsuit Alert: Investors with substantial losses from shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) purchased between Aug. 2024 and Feb. 2025 should contact the Shareholders Foundation"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/824419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=824419"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/824419\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=824419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=824419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=824419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}